L-Arginine and Asymmetric Dimethylarginine Are Early Predictors for Survival in Septic Patients with Acute Liver Failure

Table 1

Baseline data of 60 patients in the septic group, 30 patients in the surgical group and 30 individuals in the healthy group.

Septic Group (𝑛=60)
Demographic Data
Age, y	69 ± 12; 70; 64–76
Male sex	46 (76.7%)
ASA-Status: I; II; III; IV; V	1 (1.7%); 11 (18.3%); 29 (48.3%); 15 (25.0%); 1 (1.7%)
Primary site of infection/septic focus (Double naming feasible)
Lung	12 (20.0%)
Gastrointestinal tract	32 (53.3%)
Genitourinary tract	6 (10.0%)
Surgical site	16 (26.7%)
Others	2 (3.3%)
Septic complications/organ failures [Sepsis Onset—28 d]
Acute renal failure (ARF)	35 (58.3%)
Acute respiratory distress syndrome (ARDS)	49 (81.2%)
Acute liver failure (ALF)	15 (25.0%)
Surgical Group (𝑛=30)
Demographic Data
Age, y	61 ± 12; 62; 57–70
Male sex	16 (53.3%)
ASA-Status: I; II; III; IV; V	0 (0.0%); 9 (30.0%); 20 (66.7%); 1 (3.3%); 0 (0.0%)
Site of surgery (Double naming feasible)
Liver	7 (23.3%)
Pancreas	11 (36.7%)
Gastro-intestinal	27 (90.0%)
Healthy Group (𝑛=30)
Demographic Data
Age	27 ± 6; 26; 24–28
Male sex	19 (63.3%)
ASA-Status: I; II; III; IV; V	21 (70.0%); 9 (30.0%); 0 (0.0%); 0 (0.0%); 0 (0.0%)

Data are presented by number (%) or by mean ± standard deviation, median and interquartile range (Q1–Q3). Abbreviations: ASA-Status, physical status classification system according to the American Society of Anesthesiologists; ARF, acute renal failure; ARDS, acute respiratory distress syndrome; ALF, acute liver failure.